English
简体中文
Total: £ 56.28
Published Date: 2026-08-29 | Pages: 114 | Tables: 112 | Medical Care
The global Dengue Rapid Test market was valued at US$ 626 million in 2025 and is anticipated to reach US$ 952 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Dengue Rapid Test is an in vitro diagnostic (IVD) product based on immunochromatography or other rapid immunoassay techniques. It is used to detect antigens or antibodies related to the dengue virus in human samples within a short time (usually 15–20 minutes), thereby enabling rapid screening or auxiliary diagnosis of dengue infection.
Gross Profit Margin Level
As a typical immunochromatographic point-of-care testing (POCT) in vitro diagnostic product, the dengue fever rapid test generally has a mid-to-high gross profit margin in the IVD industry, but exhibits a clear stratified structure. From a supply chain perspective, relying on external procurement for key upstream raw materials such as monoclonal antibodies, recombinant antigens, and membrane materials can constrain costs, while companies with the ability to independently develop core raw materials can typically significantly improve their gross profit margin. In terms of business models, the OEM/white-label supply model, due to intense price competition and orders primarily based on large-volume bidding, generally has a gross profit margin of approximately 35%–50%; while the own-brand + registration and certification + channel distribution model can achieve a gross profit margin of around 50%–65%; further entry into hospital terminals, government projects, and international organization procurement systems, through brand premium and technological endorsement, can further increase the gross profit margin. In addition, the industry's gross profit margin is also affected by the fluctuations of the pandemic cycle, regional price systems (significant differences between developed and developing countries), and channel levels (direct sales or multi-level distribution). Overall, dengue fever rapid testing is not a "low-end test strip" business, but rather a structurally driven industry where profitability is determined by raw material capabilities, registration capabilities, and distribution channels.
Industry Drivers
The core growth of the dengue fever rapid testing industry stems from the dual drivers of "disease spread + early diagnosis." On the one hand, with climate change, accelerated urbanization, and the expansion of mosquito vector distribution, the geographical coverage of dengue fever continues to expand, with an increasing incidence and case size, providing a long-term, rigid foundation for testing demand. On the other hand, healthcare systems are shifting from "confirmatory diagnosis" to "screening diagnosis," especially in tropical and subtropical regions, where primary healthcare institutions and public health systems are increasingly reliant on rapid, low-cost, point-of-care testing (POCT) methods. Simultaneously, the increasing clinical demand for early diagnosis has also driven the widespread adoption of NS1 antigen and antibody combination tests, thereby improving testing coverage. Furthermore, the continued expansion of public health projects led by international organizations and governments (such as epidemic surveillance, emergency stockpiling, and large-scale screening) provides a stable source of demand for the industry. With the added trend of multi-pathogen testing (such as dengue fever + Zika + chikungunya), the industry is upgrading from single testing products to platform-based and combined solutions. Overall, the industry's growth is not driven by short-term epidemics, but rather by a medium- to long-term expansion logic shaped by changes in epidemiology, upgrades to primary healthcare systems, and increased investment in public health.
This report delivers a comprehensive overview of the global Dengue Rapid Test market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Dengue Rapid Test. The Dengue Rapid Test market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Dengue Rapid Test market comprehensively. Regional market sizes by Type, by Application, by Technical Principles, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dengue Rapid Test manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Abbott
SD Biosensor
bioMérieux
CTK Biotech
Wondfo
Roche Diagnostics
ACON Biotech
InBios International
CTK Biotech
Bio-Rad Laboratories
DiaSorin Group
Siemens Healthineers
Thermo Fisher Scientific
Reszon Diagnostics International
Segment by Type
NS1 Antigen Detection
IgM Antibody Detection
IgG Antibody Detection
Others
Segment by Technical Principles
Colloidal Gold Immunochromatography
ELISA
Latex Agglutination
Others
Segment by Product Form
Test Cards
Test Strips
Microplates
Others
Segment by Application
Healthcare Industry
Public Health Sector
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Technical Principles, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Dengue Rapid Test companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dengue Rapid Test Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 NS1 Antigen Detection
1.2.3 IgM Antibody Detection
1.2.4 IgG Antibody Detection
1.2.5 Others
1.3 Market by Technical Principles
1.3.1 Global Dengue Rapid Test Market Size Growth Rate by Technical Principles: 2021 vs 2025 vs 2032
1.3.2 Colloidal Gold Immunochromatography
1.3.3 ELISA
1.3.4 Latex Agglutination
1.3.5 Others
1.4 Market by Product Form
1.4.1 Global Dengue Rapid Test Market Size Growth Rate by Product Form: 2021 vs 2025 vs 2032
1.4.2 Test Cards
1.4.3 Test Strips
1.4.4 Microplates
1.4.5 Others
1.5 Market by Application
1.5.1 Global Dengue Rapid Test Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Healthcare Industry
1.5.3 Public Health Sector
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Dengue Rapid Test Market Perspective (2021–2032)
2.2 Global Dengue Rapid Test Growth Trends by Region
2.2.1 Global Dengue Rapid Test Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Dengue Rapid Test Historic Market Size by Region (2021–2026)
2.2.3 Dengue Rapid Test Forecasted Market Size by Region (2027–2032)
2.3 Dengue Rapid Test Market Dynamics
2.3.1 Dengue Rapid Test Industry Trends
2.3.2 Dengue Rapid Test Market Drivers
2.3.3 Dengue Rapid Test Market Challenges
2.3.4 Dengue Rapid Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dengue Rapid Test Players by Revenue
3.1.1 Global Top Dengue Rapid Test Players by Revenue (2021–2026)
3.1.2 Global Dengue Rapid Test Revenue Market Share by Players (2021–2026)
3.2 Global Top Dengue Rapid Test Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Dengue Rapid Test Revenue
3.4 Global Dengue Rapid Test Market Concentration Ratio
3.4.1 Global Dengue Rapid Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dengue Rapid Test Revenue in 2025
3.5 Global Key Players of Dengue Rapid Test Head Offices and Areas Served
3.6 Global Key Players of Dengue Rapid Test, Products and Applications
3.7 Global Key Players of Dengue Rapid Test, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Dengue Rapid Test Breakdown Data by Type
4.1 Global Dengue Rapid Test Historic Market Size by Type (2021–2026)
4.2 Global Dengue Rapid Test Forecasted Market Size by Type (2027–2032)
5 Dengue Rapid Test Breakdown Data by Application
5.1 Global Dengue Rapid Test Historic Market Size by Application (2021–2026)
5.2 Global Dengue Rapid Test Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Dengue Rapid Test Market Size (2021–2032)
6.2 North America Dengue Rapid Test Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Dengue Rapid Test Market Size by Country (2021–2026)
6.4 North America Dengue Rapid Test Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dengue Rapid Test Market Size (2021–2032)
7.2 Europe Dengue Rapid Test Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Dengue Rapid Test Market Size by Country (2021–2026)
7.4 Europe Dengue Rapid Test Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Dengue Rapid Test Market Size (2021–2032)
8.2 Asia-Pacific Dengue Rapid Test Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Dengue Rapid Test Market Size by Region (2021–2026)
8.4 Asia-Pacific Dengue Rapid Test Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Dengue Rapid Test Market Size (2021–2032)
9.2 Latin America Dengue Rapid Test Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Dengue Rapid Test Market Size by Country (2021–2026)
9.4 Latin America Dengue Rapid Test Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dengue Rapid Test Market Size (2021–2032)
10.2 Middle East & Africa Dengue Rapid Test Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Dengue Rapid Test Market Size by Country (2021–2026)
10.4 Middle East & Africa Dengue Rapid Test Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Dengue Rapid Test Introduction
11.1.4 Abbott Revenue in Dengue Rapid Test Business (2021–2026)
11.1.5 Abbott Recent Development
11.2 SD Biosensor
11.2.1 SD Biosensor Company Details
11.2.2 SD Biosensor Business Overview
11.2.3 SD Biosensor Dengue Rapid Test Introduction
11.2.4 SD Biosensor Revenue in Dengue Rapid Test Business (2021–2026)
11.2.5 SD Biosensor Recent Development
11.3 bioMérieux
11.3.1 bioMérieux Company Details
11.3.2 bioMérieux Business Overview
11.3.3 bioMérieux Dengue Rapid Test Introduction
11.3.4 bioMérieux Revenue in Dengue Rapid Test Business (2021–2026)
11.3.5 bioMérieux Recent Development
11.4 CTK Biotech
11.4.1 CTK Biotech Company Details
11.4.2 CTK Biotech Business Overview
11.4.3 CTK Biotech Dengue Rapid Test Introduction
11.4.4 CTK Biotech Revenue in Dengue Rapid Test Business (2021–2026)
11.4.5 CTK Biotech Recent Development
11.5 Wondfo
11.5.1 Wondfo Company Details
11.5.2 Wondfo Business Overview
11.5.3 Wondfo Dengue Rapid Test Introduction
11.5.4 Wondfo Revenue in Dengue Rapid Test Business (2021–2026)
11.5.5 Wondfo Recent Development
11.6 Roche Diagnostics
11.6.1 Roche Diagnostics Company Details
11.6.2 Roche Diagnostics Business Overview
11.6.3 Roche Diagnostics Dengue Rapid Test Introduction
11.6.4 Roche Diagnostics Revenue in Dengue Rapid Test Business (2021–2026)
11.6.5 Roche Diagnostics Recent Development
11.7 ACON Biotech
11.7.1 ACON Biotech Company Details
11.7.2 ACON Biotech Business Overview
11.7.3 ACON Biotech Dengue Rapid Test Introduction
11.7.4 ACON Biotech Revenue in Dengue Rapid Test Business (2021–2026)
11.7.5 ACON Biotech Recent Development
11.8 InBios International
11.8.1 InBios International Company Details
11.8.2 InBios International Business Overview
11.8.3 InBios International Dengue Rapid Test Introduction
11.8.4 InBios International Revenue in Dengue Rapid Test Business (2021–2026)
11.8.5 InBios International Recent Development
11.9 CTK Biotech
11.9.1 CTK Biotech Company Details
11.9.2 CTK Biotech Business Overview
11.9.3 CTK Biotech Dengue Rapid Test Introduction
11.9.4 CTK Biotech Revenue in Dengue Rapid Test Business (2021–2026)
11.9.5 CTK Biotech Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Dengue Rapid Test Introduction
11.10.4 Bio-Rad Laboratories Revenue in Dengue Rapid Test Business (2021–2026)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 DiaSorin Group
11.11.1 DiaSorin Group Company Details
11.11.2 DiaSorin Group Business Overview
11.11.3 DiaSorin Group Dengue Rapid Test Introduction
11.11.4 DiaSorin Group Revenue in Dengue Rapid Test Business (2021–2026)
11.11.5 DiaSorin Group Recent Development
11.12 Siemens Healthineers
11.12.1 Siemens Healthineers Company Details
11.12.2 Siemens Healthineers Business Overview
11.12.3 Siemens Healthineers Dengue Rapid Test Introduction
11.12.4 Siemens Healthineers Revenue in Dengue Rapid Test Business (2021–2026)
11.12.5 Siemens Healthineers Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Details
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Dengue Rapid Test Introduction
11.13.4 Thermo Fisher Scientific Revenue in Dengue Rapid Test Business (2021–2026)
11.13.5 Thermo Fisher Scientific Recent Development
11.14 Reszon Diagnostics International
11.14.1 Reszon Diagnostics International Company Details
11.14.2 Reszon Diagnostics International Business Overview
11.14.3 Reszon Diagnostics International Dengue Rapid Test Introduction
11.14.4 Reszon Diagnostics International Revenue in Dengue Rapid Test Business (2021–2026)
11.14.5 Reszon Diagnostics International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Dengue Rapid Test Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of NS1 Antigen Detection
Table 3. Key Players of IgM Antibody Detection
Table 4. Key Players of IgG Antibody Detection
Table 5. Key Players of Others
Table 6. Global Dengue Rapid Test Market Size Growth Rate by Technical Principles (US$ Million): 2021 vs 2025 vs 2032
Table 7. Key Players of Colloidal Gold Immunochromatography
Table 8. Key Players of ELISA
Table 9. Key Players of Latex Agglutination
Table 10. Key Players of Others
Table 11. Global Dengue Rapid Test Market Size Growth Rate by Product Form (US$ Million): 2021 vs 2025 vs 2032
Table 12. Key Players of Test Cards
Table 13. Key Players of Test Strips
Table 14. Key Players of Microplates
Table 15. Key Players of Others
Table 16. Global Dengue Rapid Test Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Dengue Rapid Test Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 18. Global Dengue Rapid Test Market Size by Region (US$ Million), 2021–2026
Table 19. Global Dengue Rapid Test Market Share by Region (2021–2026)
Table 20. Global Dengue Rapid Test Forecasted Market Size by Region (US$ Million), 2027–2032
Table 21. Global Dengue Rapid Test Market Share by Region (2027–2032)
Table 22. Dengue Rapid Test Market Trends
Table 23. Dengue Rapid Test Market Drivers
Table 24. Dengue Rapid Test Market Challenges
Table 25. Dengue Rapid Test Market Restraints
Table 26. Global Dengue Rapid Test Revenue by Players (US$ Million), 2021–2026
Table 27. Global Dengue Rapid Test Market Share by Players (2021–2026)
Table 28. Global Top Dengue Rapid Test Players by Tier (Tier 1, Tier 2, and Tier 3), based on Dengue Rapid Test Revenue, 2025
Table 29. Ranking of Global Top Dengue Rapid Test Companies by Revenue (US$ Million) in 2025
Table 30. Global 5 Largest Players Market Share by Dengue Rapid Test Revenue (CR5 and HHI), 2021–2026
Table 31. Global Key Players of Dengue Rapid Test, Headquarters and Area Served
Table 32. Global Key Players of Dengue Rapid Test, Products and Applications
Table 33. Global Key Players of Dengue Rapid Test, Date of General Availability (GA)
Table 34. Mergers and Acquisitions, Expansion Plans
Table 35. Global Dengue Rapid Test Market Size by Type (US$ Million), 2021–2026
Table 36. Global Dengue Rapid Test Revenue Market Share by Type (2021–2026)
Table 37. Global Dengue Rapid Test Forecasted Market Size by Type (US$ Million), 2027–2032
Table 38. Global Dengue Rapid Test Revenue Market Share by Type (2027–2032)
Table 39. Global Dengue Rapid Test Market Size by Application (US$ Million), 2021–2026
Table 40. Global Dengue Rapid Test Revenue Market Share by Application (2021–2026)
Table 41. Global Dengue Rapid Test Forecasted Market Size by Application (US$ Million), 2027–2032
Table 42. Global Dengue Rapid Test Revenue Market Share by Application (2027–2032)
Table 43. North America Dengue Rapid Test Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. North America Dengue Rapid Test Market Size by Country (US$ Million), 2021–2026
Table 45. North America Dengue Rapid Test Market Size by Country (US$ Million), 2027–2032
Table 46. Europe Dengue Rapid Test Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Europe Dengue Rapid Test Market Size by Country (US$ Million), 2021–2026
Table 48. Europe Dengue Rapid Test Market Size by Country (US$ Million), 2027–2032
Table 49. Asia-Pacific Dengue Rapid Test Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 50. Asia-Pacific Dengue Rapid Test Market Size by Region (US$ Million), 2021–2026
Table 51. Asia-Pacific Dengue Rapid Test Market Size by Region (US$ Million), 2027–2032
Table 52. Latin America Dengue Rapid Test Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 53. Latin America Dengue Rapid Test Market Size by Country (US$ Million), 2021–2026
Table 54. Latin America Dengue Rapid Test Market Size by Country (US$ Million), 2027–2032
Table 55. Middle East & Africa Dengue Rapid Test Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 56. Middle East & Africa Dengue Rapid Test Market Size by Country (US$ Million), 2021–2026
Table 57. Middle East & Africa Dengue Rapid Test Market Size by Country (US$ Million), 2027–2032
Table 58. Abbott Company Details
Table 59. Abbott Business Overview
Table 60. Abbott Dengue Rapid Test Product
Table 61. Abbott Revenue in Dengue Rapid Test Business (US$ Million), 2021–2026
Table 62. Abbott Recent Development
Table 63. SD Biosensor Company Details
Table 64. SD Biosensor Business Overview
Table 65. SD Biosensor Dengue Rapid Test Product
Table 66. SD Biosensor Revenue in Dengue Rapid Test Business (US$ Million), 2021–2026
Table 67. SD Biosensor Recent Development
Table 68. bioMérieux Company Details
Table 69. bioMérieux Business Overview
Table 70. bioMérieux Dengue Rapid Test Product
Table 71. bioMérieux Revenue in Dengue Rapid Test Business (US$ Million), 2021–2026
Table 72. bioMérieux Recent Development
Table 73. CTK Biotech Company Details
Table 74. CTK Biotech Business Overview
Table 75. CTK Biotech Dengue Rapid Test Product
Table 76. CTK Biotech Revenue in Dengue Rapid Test Business (US$ Million), 2021–2026
Table 77. CTK Biotech Recent Development
Table 78. Wondfo Company Details
Table 79. Wondfo Business Overview
Table 80. Wondfo Dengue Rapid Test Product
Table 81. Wondfo Revenue in Dengue Rapid Test Business (US$ Million), 2021–2026
Table 82. Wondfo Recent Development
Table 83. Roche Diagnostics Company Details
Table 84. Roche Diagnostics Business Overview
Table 85. Roche Diagnostics Dengue Rapid Test Product
Table 86. Roche Diagnostics Revenue in Dengue Rapid Test Business (US$ Million), 2021–2026
Table 87. Roche Diagnostics Recent Development
Table 88. ACON Biotech Company Details
Table 89. ACON Biotech Business Overview
Table 90. ACON Biotech Dengue Rapid Test Product
Table 91. ACON Biotech Revenue in Dengue Rapid Test Business (US$ Million), 2021–2026
Table 92. ACON Biotech Recent Development
Table 93. InBios International Company Details
Table 94. InBios International Business Overview
Table 95. InBios International Dengue Rapid Test Product
Table 96. InBios International Revenue in Dengue Rapid Test Business (US$ Million), 2021–2026
Table 97. InBios International Recent Development
Table 98. CTK Biotech Company Details
Table 99. CTK Biotech Business Overview
Table 100. CTK Biotech Dengue Rapid Test Product
Table 101. CTK Biotech Revenue in Dengue Rapid Test Business (US$ Million), 2021–2026
Table 102. CTK Biotech Recent Development
Table 103. Bio-Rad Laboratories Company Details
Table 104. Bio-Rad Laboratories Business Overview
Table 105. Bio-Rad Laboratories Dengue Rapid Test Product
Table 106. Bio-Rad Laboratories Revenue in Dengue Rapid Test Business (US$ Million), 2021–2026
Table 107. Bio-Rad Laboratories Recent Development
Table 108. DiaSorin Group Company Details
Table 109. DiaSorin Group Business Overview
Table 110. DiaSorin Group Dengue Rapid Test Product
Table 111. DiaSorin Group Revenue in Dengue Rapid Test Business (US$ Million), 2021–2026
Table 112. DiaSorin Group Recent Development
Table 113. Siemens Healthineers Company Details
Table 114. Siemens Healthineers Business Overview
Table 115. Siemens Healthineers Dengue Rapid Test Product
Table 116. Siemens Healthineers Revenue in Dengue Rapid Test Business (US$ Million), 2021–2026
Table 117. Siemens Healthineers Recent Development
Table 118. Thermo Fisher Scientific Company Details
Table 119. Thermo Fisher Scientific Business Overview
Table 120. Thermo Fisher Scientific Dengue Rapid Test Product
Table 121. Thermo Fisher Scientific Revenue in Dengue Rapid Test Business (US$ Million), 2021–2026
Table 122. Thermo Fisher Scientific Recent Development
Table 123. Reszon Diagnostics International Company Details
Table 124. Reszon Diagnostics International Business Overview
Table 125. Reszon Diagnostics International Dengue Rapid Test Product
Table 126. Reszon Diagnostics International Revenue in Dengue Rapid Test Business (US$ Million), 2021–2026
Table 127. Reszon Diagnostics International Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Dengue Rapid Test Picture
Figure 2. Global Dengue Rapid Test Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Dengue Rapid Test Market Share by Type: 2025 vs 2032
Figure 4. NS1 Antigen Detection Features
Figure 5. IgM Antibody Detection Features
Figure 6. IgG Antibody Detection Features
Figure 7. Others Features
Figure 8. Global Dengue Rapid Test Market Size Comparison by Technical Principles (US$ Million), 2021–2032
Figure 9. Colloidal Gold Immunochromatography Features
Figure 10. ELISA Features
Figure 11. Latex Agglutination Features
Figure 12. Others Features
Figure 13. Global Dengue Rapid Test Market Size Comparison by Product Form (US$ Million), 2021–2032
Figure 14. Test Cards Features
Figure 15. Test Strips Features
Figure 16. Microplates Features
Figure 17. Others Features
Figure 18. Global Dengue Rapid Test Market Size by Application (US$ Million), 2021–2032
Figure 19. Global Dengue Rapid Test Market Share by Application: 2025 vs 2032
Figure 20. Healthcare Industry Case Studies
Figure 21. Public Health Sector Case Studies
Figure 22. Others Case Studies
Figure 23. Dengue Rapid Test Report Years Considered
Figure 24. Global Dengue Rapid Test Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 25. Global Dengue Rapid Test Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 26. Global Dengue Rapid Test Market Share by Region: 2025 vs 2032
Figure 27. Global Dengue Rapid Test Market Share by Players in 2025
Figure 28. Global Dengue Rapid Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 29. The Top 10 and 5 Players Market Share by Dengue Rapid Test Revenue in 2025
Figure 30. North America Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. North America Dengue Rapid Test Market Share by Country (2021–2032)
Figure 32. United States Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Canada Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Europe Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Europe Dengue Rapid Test Market Share by Country (2021–2032)
Figure 36. Germany Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. France Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. U.K. Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Italy Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Russia Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Ireland Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Asia-Pacific Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Asia-Pacific Dengue Rapid Test Market Share by Region (2021–2032)
Figure 44. China Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Japan Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. South Korea Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Southeast Asia Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. India Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Australia & New Zealand Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Latin America Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Latin America Dengue Rapid Test Market Share by Country (2021–2032)
Figure 52. Mexico Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Brazil Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Middle East & Africa Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Middle East & Africa Dengue Rapid Test Market Share by Country (2021–2032)
Figure 56. Israel Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. Saudi Arabia Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 58. UAE Dengue Rapid Test Market Size YoY Growth (US$ Million), 2021–2032
Figure 59. Abbott Revenue Growth Rate in Dengue Rapid Test Business (2021–2026)
Figure 60. SD Biosensor Revenue Growth Rate in Dengue Rapid Test Business (2021–2026)
Figure 61. bioMérieux Revenue Growth Rate in Dengue Rapid Test Business (2021–2026)
Figure 62. CTK Biotech Revenue Growth Rate in Dengue Rapid Test Business (2021–2026)
Figure 63. Wondfo Revenue Growth Rate in Dengue Rapid Test Business (2021–2026)
Figure 64. Roche Diagnostics Revenue Growth Rate in Dengue Rapid Test Business (2021–2026)
Figure 65. ACON Biotech Revenue Growth Rate in Dengue Rapid Test Business (2021–2026)
Figure 66. InBios International Revenue Growth Rate in Dengue Rapid Test Business (2021–2026)
Figure 67. CTK Biotech Revenue Growth Rate in Dengue Rapid Test Business (2021–2026)
Figure 68. Bio-Rad Laboratories Revenue Growth Rate in Dengue Rapid Test Business (2021–2026)
Figure 69. DiaSorin Group Revenue Growth Rate in Dengue Rapid Test Business (2021–2026)
Figure 70. Siemens Healthineers Revenue Growth Rate in Dengue Rapid Test Business (2021–2026)
Figure 71. Thermo Fisher Scientific Revenue Growth Rate in Dengue Rapid Test Business (2021–2026)
Figure 72. Reszon Diagnostics International Revenue Growth Rate in Dengue Rapid Test Business (2021–2026)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
